open access
Need to update cardiological guidelines to prevent COVID-19 related myocardial infarction and ischemic stroke
, 23, 4, 5, 6, 7, 8, 910, 1112, 5, 111314
Affiliations- Department of Emergency, Fatebenefratelli Hospital, ASST Fatebenefratelli and Sacco, Milan, Italy
- Post-graduate School of Occupational Health, Università Cattolica del Sacro Cuore, Rome, Italy
- Health Service Department, Italian State Police, Ministry of the Interior, Milan, Italy
- Henry JN Taub Department of Emergency Medicine, Baylor College of Medicine, Houston, TX, United States
- First Department of Cardiology, Medical University of Gdansk, Poland
- Laboratory of Experimental Clinical Chemistry, Amsterdam University Medical Center, Amsterdam, the Netherlands
- European Medical School, International European University, Kiev, Ukraine
- UC Davis Graduate School of Management, Davis, CA, United States
- Department of Community Medicine, College of Medicine, University of Ibadan, Oyo State, Nigeria
- Department of Community Medicine, College of Medicine, University College Hospital, Ibadan, Oyo State, Nigeria
- Polish Society of Disaster Medicine, Warsaw, Poland
- Institute of Outcomes Research, Polonia University, Czestochowa, Poland
- Research Unit, Maria Sklodowska-Curie Bialystok Oncology Center, Bialystok, Poland
- Institute of Outcomes Research, Maria Sklodowska-Curie Medical Academy, Warsaw, Poland
open access
Abstract
Abstract
About this articleTitle
Need to update cardiological guidelines to prevent COVID-19 related myocardial infarction and ischemic stroke
Journal
Issue
Article type
Letter to the Editor
Pages
174-175
Published online
2021-10-08
Page views
5537
Article views/downloads
1013
DOI
Pubmed
Bibliographic record
Cardiol J 2022;29(1):174-175.
Authors
Gabriella Nucera
Francesco Chirico
Zubaid Rafique
Natasza Gilis-Malinowska
Aleksandra Gasecka
Nataliia Litvinova
Benjamin Wang
Olayinka S. Ilesanmi
Michal Pruc
Milosz J. Jaguszewski
Lukasz Szarpak
References (9)- Dzieciatkowski T, Szarpak L, Filipiak KJ, et al. COVID-19 challenge for modern medicine. Cardiol J. 2020; 27(2): 175–183.
- Ruetzler K, Szarpak L, Filipiak K, et al. The COVID-19 pandemic — a view of the current state of the problem. Disaster Emerg Med J. 2020.
- Gasecka A, Pruc M, Kukula K, et al. Post-COVID-19 heart syndrome. Cardiol J. 2021; 28(2): 353–354.
- Katsoularis I, Fonseca-Rodríguez O, Farrington P, et al. Risk of acute myocardial infarction and ischaemic stroke following COVID-19 in Sweden: a self-controlled case series and matched cohort study. Lancet. 2021; 398(10300): 599–607.
- Azevedo RB, Botelho BG, Hollanda JV, et al. Covid-19 and the cardiovascular system: a comprehensive review. J Hum Hypertens. 2021; 35(1): 4–11.
- Paprocki M. Nonsteroidal anti-inflammatory drugs (NSAIDs) in COVID-19 patient. Disaster Emerg Med J. 2020.
- Gąsecka A, Filipiak KJ, Jaguszewski MJ. Impaired microcirculation function in COVID-19 and implications for potential therapies. Cardiol J. 2020; 27(5): 485–488.
- Vogrig A, Gigli GL, Bnà C, et al. Stroke in patients with COVID-19: Clinical and neuroimaging characteristics. Neurosci Lett. 2021; 743: 135564.
- Lim S, Bae JH, Kwon HS, et al. COVID-19 and diabetes mellitus: from pathophysiology to clinical management. Nat Rev Endocrinol. 2021; 17(1): 11–30.
